Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A R Thompson

Showing results (141-150 of 203) with videos related to

Pageof 21
Sort By:
The Journal of the Arkansas Medical Society|November 1, 1986
Squamous cell carcinoma of the supraglottic larynxW D Haynes, C A Araoz, T A Flippin, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|January 31, 2004
Successful treatment of urgent bleeding in von Willebrand disease with factor VIII/VWF concentrate (Humate-P): use of the ristocetin cofactor assay (VWF:RCo) to measure potency and to guide therapyJ Cox Gill, B M Ewenstein, A R Thompson, et al.
Surgery|December 1, 1988
Intraoperative measurement of parathyroid hormone in the surgical management of hyperparathyroidismS R Nussbaum, A R Thompson, K A Hutcheson, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|February 14, 2004
Successful treatment for patients with von Willebrand disease undergoing urgent surgery using factor VIII/VWF concentrate (Humate-P)A R Thompson, J C Gill, B M Ewenstein, et al.
The Journal of the Arkansas Medical Society|April 1, 1987
Carcinoma of the larynx and pharynxA R Thompson, W E Atkinson, A P Bucolo, et al.
British Journal of Haematology|June 1, 1980
Human factor IX in animals: kinetics from isolated, radiolabelled protein and platelet destruction following crude concentrate infusionsA R Thompson, A W Forrey, P A Gentry, et al.
Thrombosis and Haemostasis|October 5, 2001
Factor IX Denver, ASN 346-->ASP mutation resulting in a dysfunctional protein with defective factor VIIIa interactionJ B Lefkowitz, R Nuss, T Haver, et al.
Blood|September 15, 1991
Treatment type and amount influenced human immunodeficiency virus seroprevalence of patients with congenital bleeding disordersG F Gjerset, M J Clements, R B Counts, et al.
Journal of Thrombosis and Haemostasis : JTH|November 24, 2007
T-cell responses over time in a mild hemophilia A inhibitor subject: epitope identification and transient immunogenicity of the corresponding self-peptideE A James, W W Kwok, R A Ettinger, et al.
British Journal of Haematology|November 1, 1986
Danazol fails to increase factor VIII or IX levels in a double-blind crossover study of patients with haemophilia A and BD J Nugent, G L Bray, R B Counts, et al.
Pageof 21

Showing results (141-150 of 203) with videos related to

Sort By:
Pageof 21
The Journal of the Arkansas Medical Society|November 1, 1986
Squamous cell carcinoma of the supraglottic larynxW D Haynes, C A Araoz, T A Flippin, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|January 31, 2004
Successful treatment of urgent bleeding in von Willebrand disease with factor VIII/VWF concentrate (Humate-P): use of the ristocetin cofactor assay (VWF:RCo) to measure potency and to guide therapyJ Cox Gill, B M Ewenstein, A R Thompson, et al.
Surgery|December 1, 1988
Intraoperative measurement of parathyroid hormone in the surgical management of hyperparathyroidismS R Nussbaum, A R Thompson, K A Hutcheson, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|February 14, 2004
Successful treatment for patients with von Willebrand disease undergoing urgent surgery using factor VIII/VWF concentrate (Humate-P)A R Thompson, J C Gill, B M Ewenstein, et al.
The Journal of the Arkansas Medical Society|April 1, 1987
Carcinoma of the larynx and pharynxA R Thompson, W E Atkinson, A P Bucolo, et al.
British Journal of Haematology|June 1, 1980
Human factor IX in animals: kinetics from isolated, radiolabelled protein and platelet destruction following crude concentrate infusionsA R Thompson, A W Forrey, P A Gentry, et al.
Thrombosis and Haemostasis|October 5, 2001
Factor IX Denver, ASN 346-->ASP mutation resulting in a dysfunctional protein with defective factor VIIIa interactionJ B Lefkowitz, R Nuss, T Haver, et al.
Blood|September 15, 1991
Treatment type and amount influenced human immunodeficiency virus seroprevalence of patients with congenital bleeding disordersG F Gjerset, M J Clements, R B Counts, et al.
Journal of Thrombosis and Haemostasis : JTH|November 24, 2007
T-cell responses over time in a mild hemophilia A inhibitor subject: epitope identification and transient immunogenicity of the corresponding self-peptideE A James, W W Kwok, R A Ettinger, et al.
British Journal of Haematology|November 1, 1986
Danazol fails to increase factor VIII or IX levels in a double-blind crossover study of patients with haemophilia A and BD J Nugent, G L Bray, R B Counts, et al.
Pageof 21